Steven Seedhouse analyst RAYMOND JAMES

Currently out of the existing stock ratings of Steven Seedhouse, 241 are a BUY (93.77%), 15 are a HOLD (5.84%), 1 are a SELL (0.39%).

Steven Seedhouse

Work Performance Price Targets & Ratings Chart

Analyst Steven Seedhouse works at RAYMOND JAMES with a stock forecast success ratio of 37.71% fulfilled within 295.13 days on average.

Steven Seedhouse’s has documented 456 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on VKTX, Viking Therapeutics at 27-Feb-2024.

Wall Street Analyst Steven Seedhouse

Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.

Average potential price target upside

ALXN Alexion Pharmaceuticals APLS Apellis Pharmaceuticals ARCT Arcturus Therapeutics Holdings BIIB Biogen CBAY Cymabay Therapeu CCXI ChemoCentryx EDIT Editas Medicine ETN Eaton PLC GILD Gilead Sciences ICPT Intercept Pharmaceuticals IFRX InflaRx N.V. JNCE Jounce Therapeutics KDMN Kadmon Holdings MIRM Mirum Pharmaceuticals NG NovaGold Resources NGM NGM Biopharmaceuticals NTLA Intellia Therapeutics VBIV VBI Vaccines VKTX Viking Therapeutics GLMD Galmed Pharmaceuticals Ltd PRQR ProQR Therapeutics BV DYN Dyne Therapeutics  GOSS Gossamer Bio RCKT Rocket Pharmaceuticals LABP Landos Biopharma ETNB 89bio LPTX Leap Therapeutics RNA Avidity Biosciences  NEXI Neximmune ANAB AnaptysBio ARDX Ardelyx VERA Vera Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

205

$22.5 (12.33%)

2 years 11 months 18 days ago

3/5 (60%)

$35.09 (20.65%)

938

Hold

173

$-9.5 (-5.21%)

156

2 years 11 months 20 days ago

14/24 (58.33%)

$2.73 (1.60%)

682

Hold

190

$7.5 (4.11%)

194

3 years 2 months 19 days ago

9/11 (81.82%)

$34.41 (22.12%)

350

Hold

166

$-16.5 (-9.04%)

175

3 years 2 months 19 days ago

23/23 (100%)

$10.41 (6.69%)

828

Buy

155

3 years 3 months 16 days ago

7/7 (100%)

$36.79 (31.12%)

395

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Steven Seedhouse is most bullish on?

Potential upside of $58.36 has been obtained for APLS (APELLIS PHARMACEUTICALS)

Which stock is Steven Seedhouse is most reserved on?

Potential downside of -$2.13 has been obtained for VERA (VERA THERAPEUTICS)

What Year was the first public recommendation made by Steven Seedhouse?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?